Exhibit 1

JOINT FILING AGREEMENT

         The undersigned parties hereby agree that this Schedule 13D filed herewith relating to the American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share of Chemomab Therapeutics Ltd., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) on behalf of each such person.

Date: January 20, 2022

/s/ Adi Mor

ADI MOR

/s/ Kobi George

KOBI GEORGE